{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for beta root_names_name in Any Name (approximate match)
Status:
Investigational
Source:
NCT00742443: Phase 3 Interventional Completed Cicatrix
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00278187: Phase 2 Interventional Unknown status Lung Cancer
(2005)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01760005: Phase 2/Phase 3 Interventional Recruiting Alzheimers Disease
(2012)
Source URL:
Class:
PROTEIN
Status:
Designated
Source:
FDA ORPHAN DRUG:768120
Source URL:
Class:
PROTEIN